Melanotan II vs Tesofensine
Head-to-head comparison of Melanotan II and Tesofensine for research applications. Both peptides are studied for various research applications, but they differ significantly in mechanism and evidence level.
Side-by-Side Comparison
| Attribute | Melanotan Ii | Tesofensine |
|---|---|---|
| Category | Melanocortin Agonist | Weight Loss / Reuptake Inhibitor |
| Mechanism | MT-II activates melanocortin receptors MC1R through MC5R non-selectively. MC1R activation stimulates melanogenesis (skin tanning) in melanocytes. | Tesofensine inhibits the presynaptic reuptake of serotonin, norepinephrine, and dopamine, increasing synaptic concentrations of all three monoamines. |
| Evidence Rating | F — No Regulatory Activity | C — Phase II–III Clinical Trials |
| Clinical Status | Research-only / Not approved. Multiple regulatory warnings issued worldwide. | Phase 3 clinical trials (Saniona). Phase 2 completed with significant weight loss results. |
| Safety Profile | Nausea (very common, especially at initial doses); Facial flushing and warmth | Phase 2 trials reported increased heart rate (5-8 bpm) and blood pressure elevation at higher doses; Common side effects: dry mouth, insomnia, constipation, nausea, diarrhea |
| Molecular Weight | ~1024.2 g/mol | ~397.5 g/mol |
| Half-Life | ~36 minutes IV; longer SC due to depot effect | N/A |
Overview
Melanotan II and Tesofensine are both research peptides studied across multiple applications. This comparison examines their mechanisms, evidence base, and safety profiles to help researchers understand the key differences and overlaps.
Melanotan II — Mechanism & Evidence
Melanotan II is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone (alpha-MSH) that non-selectively activates melanocortin receptors MC1R through MC5R. Originally developed for photoprotective skin tanning, it also affects sexual function (MC3R/MC4R) and appetite (MC4R). PT-141 (bremelanotide) was derived from MT-II research as its active metabolite responsible for sexual arousal effects. MT-II is not approved for human use in any country, and multiple regulatory agencies have issued explicit safety warnings against its use.
Key claims: Causes skin tanning without UV exposure; Increases sexual desire and arousal; Suppresses appetite.
Tesamorelin 10mg
10mg
Tesofensine — Mechanism & Evidence
Tesofensine is a triple monoamine reuptake inhibitor (serotonin, norepinephrine, dopamine) originally developed for Alzheimer's and Parkinson's disease. Phase 2 trials demonstrated approximately 10% body weight loss over 24 weeks, making it one of the most effective weight loss agents studied to date. It is not technically a peptide but is frequently discussed alongside peptide-based weight loss therapies. The compound was developed by NeuroSearch A/S and later licensed to Saniona, which is pursuing Phase 3 trials.
Key claims: Produces significant weight loss (~10% body weight); Suppresses appetite and reduces caloric intake; Increases resting metabolic rate.
Shared Research Applications
These peptides target different research areas. Melanotan II focuses on Tanning, Sexual Health, while Tesofensine targets Weight Loss, Appetite Suppression.
Safety Considerations
Melanotan II: Nausea (very common, especially at initial doses) Facial flushing and warmth Spontaneous erections (in males)
Tesofensine: Phase 2 trials reported increased heart rate (5-8 bpm) and blood pressure elevation at higher doses Common side effects: dry mouth, insomnia, constipation, nausea, diarrhea Psychiatric effects reported: anxiety, mood changes (consistent with monoamine reuptake inhibitors)
Shop Research Peptides
Quality Documentation
Review batch documentation before making research purchasing decisions. Volta pairs product education with COA literacy so researchers can evaluate purity, identity, lot details, and testing context.
Product cards on this page link to current catalog entries and available quality documentation.
Related Research News
Tesofensine: Triple Monoamine Reuptake Inhibitor in Metabolic Research
Tesofensine triple monoamine reuptake inhibitor metabolic research preclinical evidence mechanisms safety
Melanotan II: Facts, Mechanism, and Research Overview
Explore Melanotan II research: its mechanism as a melanocortin agonist, preclinical findings, evidence limitations, and safety considerations for laboratory studies.